Crossmark

Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection

Crossref DOI link: https://doi.org/10.1186/s12879-019-3789-6

Published Online: 2019-02-14

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stalenhoef, Janneke Evelyne http://orcid.org/0000-0003-1486-3045
van Nieuwkoop, Cees

Wilson, Darius Cameron

van der Starre, Willize Elizabeth

van der Reijden, Tanny J. K.

Delfos, Nathalie Manon

Leyten, Eliane Madeleine Sophie

Koster, Ted

Ablij, Hans Christiaan

van ‘t Wout, Johannes (Jan) Willem

van Dissel, Jaap Tamino
Funding

Funding for this research was provided by:

ZonMw (171101003)

Bronovo Research Foundation (001)

Franje1 Foundation (001)
License Information

Text and Data Mining valid from 2019-02-14
More Information

Article History

Received: 25 September 2018

Accepted: 7 February 2019

First Online: 14 February 2019

Ethics approval and consent to participate

: The study protocol was primarily approved by the Medical Ethics Committee of the Leiden University Medical Center (protocol P08.65) and subsequently by all scientific boards of all participating centers. All patients have given written informed consent.

: Not Applicable.

: Darius Wilson is employed by Thermo Fisher Scientific / Brahms, Hennigsdorf, Germany. All other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below